Ovarian Clinical Trials
Delivering quality care through clinical trials
Available clinical trials are below. Click the + sign to expand and review details about their purpose, eligibility criteria, and contact information for study staff. For some studies, you will find a link to ClinicalTrials.gov, where you can explore more information about each study.
Gradalis - CL-PTL-135
Study Phase: Biospecimen Review
Condition(s): Ovarian cancer
Blood and Tissue Procurement Protocol for Product Development and Research
Study Purpose
The purpose of this research is to collect cancerous tissue/fluid and blood samples to store and use for research purposes. The samples may be used by researchers to learn more about developing cancer treatment.
Eligibility Criteria
- Patients must agree to collection of blood and/or tumor tissue/fluid that is obtained during a standard of care procedure or visit (as of 5/11/23 - no blood collection is necessary unless specifically requested by sponsor)
- For Ovarian cancer - fresh tissue collection of frontline, newly diagnosed, treatment naive, Stage IIIb or IV or first recurrenct, platinum-sensitive tumors (tissue collection must occur prior to initiation of any systemic therapy for recurrence)
- For Ovarian cancer - fluid collection from first tap of ascites or pleural fluid of first recurrence, platinum-sensitive tumors (can be collected prior to or after systemic therapy for recurrence is initiated)
NRG - NRG-GY036
Study Phase: Phase III - Drug
Condition(s): BRCA 1/2 mutated or HRD+ ovarian cancer
A Phase III Trial of One vs. Two Years of Maintenance Olaparib, With or Without Bevacizumab, in Patients With BRCA 1/2 Mutated or Homologous Recombination Deficient (HRD+) Ovarian Cancer Following Response to First Line Platinum Based Chemotherapy
ClinicalTrials.gov NCT ID: NCT06580314
You can view the full clinical description on ClinicalTrials.gov.
View Full Description
MD Anderson 2020-0165 (LANCE)
Study Phase: Phase III - surgical observation
Condition(s): Ovarian cancer stage IIIC or IV high-grade
Laparoscopic Cytoreduction After Neoadjuvant Chemotherapy
ClinicalTrials.gov NCT ID: NCT04575935
You can view the full clinical description on ClinicalTrials.gov.
View Full Description
To inquire if you're eligible for a clinical trial, contact: (484) 658-5080, or click here to complete a clinical trial inquiry form.
